Download PDF
Geburtshilfe Frauenheilkd 2006; 66(2): R30-R43
DOI: 10.1055/s-2006-923869
GebFra-Refresher

Georg Thieme Verlag KG Stuttgart · New York

Dysmenorrhö und Prämenstruelles Syndrom

B. Sonntag1
  • 1Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Münster
Further Information

Publication History

Publication Date:
07 March 2006 (online)

Also available at
    Permissions and Reprints

Menstruationsbedingte Beschwerden zählen zu den häufigsten Ursachen frauenärztlicher Konsultationen. Sie beeinträchtigen nicht nur im erheblichen Maße die Lebensqualität der Betroffenen, sondern sind als häufiger Grund für die Inanspruchnahme ärztlicher Leistungen sowie Ursache einer Arbeitsunfähigkeit auch sozioökonomisch bedeutsame Faktoren [[1], [2], [3]]. Zu den häufigsten subjektiv wahrgenommenen Beschwerden zählen hierbei die Dysmenorrhö und das Prämenstruelle Syndrom.

Literatur

  • 1 Braunstein J B, Hausfeld J, London A. Economics of reducing menstruation with trimonthly-cycle oral contraceptive therapy: comparison with standard-cycle regimens.  Obstet Gynecol. 2003;  102 699-708
    CrossrefPubMedGoogle Scholar
  • 2 Cote I, Jacobs P, Cumming D. Work loss associated with increased menstrual loss in the United States.  Obstet Gynecol. 2002;  100 683-687
    CrossrefPubMedGoogle Scholar
  • 3 Jones G L, Kennedy S H, Jenkinson C. Health-related quality of life measurement in women with common benign gynecologic conditions: a systematic review.  Am J Obstet Gynecol. 2002;  187 501-511
    CrossrefPubMedGoogle Scholar
  • 4 Lichten E M, Bombard J. Surgical treatment of primary dysmenorrhea with laparoscopic uterine nerve ablation.  J Reprod Med. 1987;  32 37-41
    PubMedGoogle Scholar
  • 5 Bravermann P K, Neinstein L S. Dysmenorrhea and Premenstrual Syndrome in Adolescent Health Care: A Practical Guide. Philadelphia; Lippincott Williams & Wilkins 2002
    Google Scholar
  • 6 Dawood M Y. Dysmenorrhea.  Clin Obstet Gynecol. 1990;  33 168-178
    CrossrefPubMedGoogle Scholar
  • 7 Rosenwaks Z, Seegar-Jones G. Menstrual pain: its origin and pathogenesis.  J Reprod Med. 1980;  25 207-212
    PubMedGoogle Scholar
  • 8 Bieglmayer C, Hofer G, Kainz C, Reinthaller A, Kopp B, Janisch H. Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives.  Gynecol Endocrinol. 1995;  9 307-312
    CrossrefPubMedGoogle Scholar
  • 9 Stromberg P, Akerlund M, Forsling M L, Granstrom E, Kindahl H. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea.  Acta Obstet Gynecol Scand. 1984;  63 533-538
    PubMedGoogle Scholar
  • 10 Melzack R, Katz J. Pain measurement in persons in pain. Wall PD, Melzack R Textbook of Pain. London; Churchill Livingstone 1994
    Google Scholar
  • 11 Moos R H. The development of a menstrual distress questionnaire.  Psychosom Med. 1968;  30 853-867
    PubMedGoogle Scholar
  • 12 Chesney M A, Tasto D L. The development of the menstrual symptom questionnaire.  Behav Res Ther. 1975;  13 237-244
    CrossrefPubMedGoogle Scholar
  • 13 Marjoribanks J, Proctor M L, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhea.  Cochrane Database Syst Rev. 2003;  CD001751
    PubMedGoogle Scholar
  • 14 Daniels S E, Talwalker S, Torri S, Snabes M C, Recker D P, Verburg K M. Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea.  Obstet Gynecol. 2002;  100 350-358
    CrossrefPubMedGoogle Scholar
  • 15 Proctor M L, Roberts H, Farquhar C M. Combined Oral Contraceptive Pill (Ocp) as Treatment for Primary Dysmenorrhea.  Cochrane Database Syst Rev. 2001;  CD002120
    PubMedGoogle Scholar
  • 16 Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives.  Drugs. 2004;  64 2447-2462
    CrossrefPubMedGoogle Scholar
  • 17 Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, Crosignani P G. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen.  Fertil Steril. 2003;  80 560-563
    CrossrefPubMedGoogle Scholar
  • 18 Lundstrom V. Endocrine pathophysiology of primary dysmenorrhea. Dawood MY, McGuire JL, Demers LM Premenstrual Syndrome and Dysmenorrhea. Baltimore; Urban & Schwarzenberg 1985
    Google Scholar
  • 19 Proctor M L, Smith C A, Farquhar C M, Stones R W. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhea.  Cochrane Database Syst Rev. 2002;  CD002123
    PubMedGoogle Scholar
  • 20 Wilson M L, Murphy P A. Herbal and dietary therapies for primary and secondary dysmenorrhea.  Cochrane Database Syst Rev. 2001;  CD002124
    PubMedGoogle Scholar
  • 21 Akin M D, Weingand K W, Hengehold D A, Goodale M B, Hinkle R T, Smith R P. Continuous low-level topical heat in the treatment of dysmenorrhea.  Obstet Gynecol. 2001;  97 343-349
    CrossrefPubMedGoogle Scholar
  • 22 Golomb L M, Solidum A A, Warren M P. Primary dysmenorrhea and physical activity.  Med Sci Sports Exerc. 1998;  30 906-909
    PubMedGoogle Scholar
  • 23 Mortola J F, Girton L, Yen S S. Depressive episodes in premenstrual syndrome.  Am J Obstet Gynecol. 1989;  161 1682-1687
    PubMedGoogle Scholar
  • 24 Reid R L. Premenstrual syndrome.  N Engl J Med. 1991;  324 1208-1210
    PubMedGoogle Scholar
  • 25 Mortola J F. Premenstrual syndrome - pathophysiologic considerations.  N Engl J Med. 1998;  338 256-257
    CrossrefPubMedGoogle Scholar
  • 26 Endicott J. History, evolution, and diagnosis of premenstrual dysphoric disorder.  J Clin Psychiatry. 2000;  61 (Suppl 12) 5-8
    Google Scholar
  • 27 Greene R, Dalton K. The premenstrual syndrome.  Br Med J. 1953;  1 1007-1014
    PubMedGoogle Scholar
  • 28 Munday M, Brush M G, Taylor R W. Progesterone and aldosterone levels in the premenstrual tension syndrome (proceedings).  J Endocrinol. 1977;  73 21P-22P
    PubMedGoogle Scholar
  • 29 Rapkin A J, Morgan M, Goldman L, Brann D W, Simone D, Mahesh V B. Progesterone metabolite allopregnanolone in women with premenstrual syndrome.  Obstet Gynecol. 1997;  90 709-714
    CrossrefPubMedGoogle Scholar
  • 30 Schmidt P J, Nieman L K, Danaceau M A, Adams L F, Rubinow D R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.  N Engl J Med. 1998;  338 209-216
    CrossrefPubMedGoogle Scholar
  • 31 Dimmock P W, Wyatt K M, Jones P W, O'Brien P M. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review.  Lancet. 2000;  356 1131-1136
    CrossrefPubMedGoogle Scholar
  • 32 Tan K S. Premenstrual asthma: epidemiology, pathogenesis and treatment.  Drugs. 2001;  61 2079-2086
    PubMedGoogle Scholar
  • 33 Maguire J L, Stell B M, Rafizadeh M, Mody I. Ovarian cycle-linked changes in GABA (A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety.  Nat Neurosci. 2005;  8 797-804
    CrossrefPubMedGoogle Scholar
  • 34 MacGregor E A, Frith A, Ellis J, Aspinall L. Predicting menstrual migraine with a home-use fertility monitor.  Neurology. 2005;  64 561-563
    PubMedGoogle Scholar
  • 35 Johnson S R. Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners.  Obstet Gynecol. 2004;  104 845-859
    PubMedGoogle Scholar
  • 36 Parry B L, Newton R P. Chronobiological basis of female-specific mood disorders.  Neuropsychopharmacology. 2001;  25 S102-S108
    CrossrefPubMedGoogle Scholar
  • 37 Rossignol A M, Bonnlander H. Caffeine-containing beverages, total fluid consumption, and premenstrual syndrome.  Am J Public Health. 1990;  80 1106-1110
    PubMedGoogle Scholar
  • 38 Freeman E W, Stout A L, Endicott J, Spiers P. Treatment of premenstrual syndrome with a carbohydrate-rich beverage.  Int J Gynecol Obstet. 2002;  77 253-254
    CrossrefPubMedGoogle Scholar
  • 39 Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.  Am J Obstet Gynecol. 1998;  179 444-452
    CrossrefPubMedGoogle Scholar
  • 40 Facchinetti F, Borella P, Sances G, Fioroni L, Nappi R E, Genazzani A R. Oral magnesium successfully relieves premenstrual mood changes.  Obstet Gynecol. 1991;  78 177-181
    PubMedGoogle Scholar
  • 41 Berger D, Schaffner W, Schrader E, Meier B, Brattstrom A. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS).  Arch Gynecol Obstet. 2000;  264 150-153
    CrossrefPubMedGoogle Scholar
  • 42 Freeman E, Rickels K, Sondheimer S J, Polansky M. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.  JAMA. 1990;  264 349-353
    CrossrefPubMedGoogle Scholar
  • 43 Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review.  BMJ. 2001;  323 776-780
    CrossrefPubMedGoogle Scholar
  • 44 Freeman E W, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, Zhang P, Patel H, Foegh M. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.  J Womens Health Gend Based Med. 2001;  10 561-569
    CrossrefPubMedGoogle Scholar
  • 45 Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.  N Engl J Med. 1995;  332 1529-1534
    CrossrefPubMedGoogle Scholar
  • 46 Yonkers K A, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline premenstrual dysphoric collaborative study group.  JAMA. 1997;  278 983-988
    CrossrefPubMedGoogle Scholar
  • 47 Wyatt K M, Dimmock P W, O'Brien P M. Selective serotonin reuptake inhibitors for premenstrual syndrome.  Cochrane Database Syst Rev. 2002;  CD001396
    PubMedGoogle Scholar
  • 48 Wyatt K M, Dimmock P W, Ismail K M, Jones P W, O'Brien P M. The effectiveness of GnRHa with and without “add-back” therapy in treating premenstrual syndrome: a meta analysis.  BJOG. 2004;  111 585-593
    CrossrefPubMedGoogle Scholar

Dr. med. Barbara Sonntag

Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe
Universitätsklinikum Münster

Albert-Schweitzer-Straße 33

48129 Münster

Email: sonntag@uni-muenster.de

      >